|
"received notice from the U.S. Food and Drug Administration (FDA) that tesetaxel, the latest addition to Genta’s oncology product portfolio, has been granted designation as an “Orphan Drug” for treatment of patients with advanced gastric cancer."
Maybe this would allow for off label BC treatment by maverick oncs? Might be worth asking. Although..I think there may be some other oral taxanes???
|